Back to top

VAN ECK MARKET VECTORS BIOTECH ETF: (AMEX : BBH)

(U.S : AMEX) As of Apr 17, 2014 03:59 PM ET

 Add to portfolio

$85.37 USD

-0.25 (-0.29%)

Volume: 123,920

Zacks ETF Rank: 1 - Strong Buy [?] 1        

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Premium - The only way to get access to the Zacks Rank

ETF Quote Details

Previous Close 85.62
Open 85.27
Bid 85.02
Ask 86.91
Day Low-High 84.90-87.10
52wk Low-High 64.25-106.82
Volume 123,920
NAV (month end) 90.93
Premium (+)/Discount (-) (month end)-5.31

Zacks Premium Research for BBH

Zacks ETF Rank [?] Strong Buy 1
ETF Risk [?] High
ETF Research Report

Learn to Profit from the Zacks Rank

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Premium - The only way to get access to the Zacks Rank

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.00 (0.00%)
Issuer VAN ECK

Benchmark for BBH

MARKET VECTORS US LISTED BIOTECH 25 INDE

This benchmark index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

Fund Summary for BBH

VAN ECK MARKET VECTORS BIOTECH ETF

The Market Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is a rules based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.